Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Trastuzumab emtansine
Sponsor: University of Rochester